Could a tiny sensor replace finger pricks for diabetic Moms-to-Be?

NCT ID NCT07184775

Recruiting now Disease control Sponsor: Thomas Jefferson University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a continuous glucose monitor (CGM) helps pregnant women with type 2 diabetes track their blood sugar better than traditional finger-stick testing. Seventy participants will be randomly assigned to use either a CGM or a glucometer from enrollment until delivery. The goal is to see which method leads to better adherence and, ultimately, healthier outcomes for mothers and babies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: continuous glucose monitor (CGM) and glucometer
What this could lead to: If CGM proves better, it could make blood sugar tracking easier and more reliable for pregnant women with type 2 diabetes, potentially reducing complications for both mother and baby.
What could go wrong: This is a small, early-stage study (70 participants) comparing monitoring methods, not testing a new treatment. The device may not improve outcomes or could be less practical for some patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONTINUOUS GLUCOSE MONITORING SYSTEM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CONTINUOUS GLUCOSE MONITORING SYSTEM PREGNANCY TYPE 2 DIABETES MELLITUS (T2DM)

Contacts and locations

Locations

Jefferson Health New Jersey
RECRUITING

Sewell, New Jersey, 08080, United States
Thomas Jefferson University
RECRUITING

Philadelphia, Pennsylvania, 19107, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.